Evidence map›Paper›PMID 37332347›Full record

ArticleFrontiers in pharmacology2023

Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor.

Laura Grohs, Linhan Cheng, Saskia Cönen, Bassam G Haddad, Astrid Bülow, Idil Toklucu, Lisa Ernst, Jannis Körner, Günther Schmalzing, Angelika Lampert and 2 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Laura GrohsInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
Linhan ChengInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
Saskia CönenInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
Bassam G HaddadMolecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, Germany.
Astrid BülowInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
Idil ToklucuInstitute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, Germany.
Lisa ErnstInstitute for Laboratory Animal Science and Experimental Surgery, RWTH Aachen University, Aachen, Germany.
Jannis KörnerInstitute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, Germany.
Günther SchmalzingInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
Angelika LampertInstitute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, Germany.
Jan-Philipp MachtensInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
Ralf HausmannInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany.
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1120360.].

Indexed as

chronic paincompetitive antagonistdrug screeningnociceptionnon-steroidal anti-inflammatory drugs (NSAIDs)P2X3 receptor

Identifiers

PMID37332347
PMCPMC10274573
OpenAlexW4379232544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.